VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO WCGIC 2020 | First real-world ctDNA analysis of oligometastic CRC

Stacey Cohen, MD, Fred Hutchinson Cancer Research Center, Seattle, WA, discusses the clinical experience of a personalized and tumor-informed circulating tumor DNA (ctDNA) assay for minimal residual disease (MRD) detection in oligometastatic colorectal cancer (CRC) patients. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter